Seres Therapeutics Inc. News
Cramer's Mad Money Recap 12/3: DocuSign, GameStop, Costco
Valuations for many stocks are high, says Jim Cramer. That means investors should be on the lookout for potential shocks and new buying opportunities.
Seres Stock Tanks After Failed Ulcerative Colitis Drug Test
Seres Therapeutics sinks after it announces a failure for a test of its ulcerative colitis drug, leading it to halt part of the trial.
Rigel Jumps on Update on FDA Review of Bleeding Disorder Treatment
The South San Francisco, Calif.-based firm said the U.S. Food and Drug Administration indicated that it does not plan to conduct an Oncology Drugs Advisory Committee meeting to discuss Rigel's new drug application for fostamatinib in chronic or persistent immune thrombocytopenia.
Premarket biotech movers: Mylan, Momenta Pharmaceuticals, Seres Therapeutics
Mylan, Momenta Pharmaceuticals and Seres Therapeutics were among the biotech stock movers in premarket trading on Tuesday.
Jim Cramer's Top Takeaways: Anadarko Petroleum, Coach, Seres Therapeutics
Cramer sees Anadarko Petroleum profiting and Coach returning to its former glory.
Jim Cramer's 'Mad Money' Recap: Are You Ready to Make Your Move?
Worried about a bad event? There will be money coming off the sidelines afterward. Be prepared to buy on weakness.
Seres therapeutics (mcrb) stock surges, fbr capital remains bullish
FBR Capital analysts are remaining bullish on Seres Therapeutics (MCRB) despite the company's second quarter earnings miss.
4 big-volume stocks to add to your buy list -- plus 3 to avoid
Here's a technical look at how to trade some of the most active stocks on the market right now.
Seres therapeutics (mcrb) stock plummets on drug failure
Seres Therapeutics (MCRB) stock is trading sharply lower after the company’s lead experimental drug failed to meet its primary endpoint.
S&P 500 and Nasdaq turn higher as Alphabet leads, Exxon falls
Stocks fluctuate on Friday morning as the mix of earnings reports again pulls Wall Street in two directions.
'Big Short' Burry Warns That a Repeat of the 2008 Crisis Is in Sight
The legendary financier reiterates his warnings of a market collapse on the way.
Oil Volatility Returns, Pushing Gasoline Prices Higher
The 14-week decline in gasoline prices ended while two million people in Florida are still without power.
New Electric Vehicle Beats Tesla When it Comes to the Environment
A new EV would radically change how cars are made and that could be a threat to the market leader.
McDonald's Menu Adds a (Very) New Take on an Old Favorite
The fast-food giant has been hesitant to make changes like this, but Wendy's bold move may have forced it to.